{"mainPropery":{"diseaseId":10940,"diseaseName":"Superior limbic keratoconjunctivitis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10940/superior-limbic-keratoconjunctivitis","synonyms":["SLK","Theodores superior limbic keratoconjunctivitis","Theodores syndrome","Theodore superior limbic keratoconjunctivitis","Theodore syndrome"],"synonyms-with-source":[{"name":"SLK"},{"name":"Theodores superior limbic keratoconjunctivitis","source":"OrphaData.Org"},{"name":"Theodores syndrome","source":"OrphaData.Org"},{"name":"Theodore superior limbic keratoconjunctivitis","source":"OrphaData.Org"},{"name":"Theodore syndrome","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"88633"}]},"diseaseCategories":[{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=superior%20limbic%20keratoconjunctivitis%20%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Superior limbic keratoconjunctivitis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=superior+limbic+keratoconjunctivitis' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Superior limbic keratoconjunctivitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1400,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled&nbsp;<a href='http://clinicaltrials.gov/ct2/show/NCT00655096?term=for+NEI+Clinical+Studies&amp;rank=3  ' target='_blank'>Screening Study for the Evaluation and Diagnosis of Potential Research Participants</a><strong> </strong>which may be of interest to you.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1194578-overview#showall' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=88633' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1564,"resourceId":2180,"resourceName":"National Eye Institute","descriptionText":"The <a href='http://www.nei.nih.gov/' target='_blank'>National Eye Institute</a> (NEI) provides more information on this topic. You can reach them by calling 301-496-5248 or by E-mail at 2020@nei.nih.gov","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:88633' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6299,"questionText":"What is superior limbic keratoconjunctivitis?","answerText":"<strong>Superior limbic keratoconjunctivitis</strong> (SLK) is a chronic and recurrent <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/1094.htm\" target=\"_blank\">eye</a> disease which affects the&nbsp;superior bulbar conjunctiva (the clear layer that covers the eyeball, over the&nbsp;<a title=\"Sclera\" href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002295.htm\" target=\"_blank\"><span style=\"color: #0645ad;\">sclera</span></a>) and tarsal conjunctiva (the clear layer that lines the eyelids), as well as the superior limbic aspect of the cornea (the area above the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/9909.htm\" target=\"_blank\">cornea</a>).[5351][5352] It is commonly found in women 20-70 years of age. The signs and symptoms include burning, redness and irritation and tend to develop slowly over a period of 1 to 10 years.[5353]&nbsp;Vision usually remains intact. While the underlying cause of&nbsp;SLK remains unknown, it is believed that the condition is&nbsp;secondary to superior bulbar conjunctiva laxity.&nbsp; Factors inducing conjunctiva laxity include &nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/thyroiddiseases.html\" target=\"_blank\">thyroid eye disease</a>&nbsp;(usually&nbsp;<a href=\"http://www.endocrine.niddk.nih.gov/pubs/Hyperthyroidism/\" target=\"_blank\">hyperthyroidism</a>), tight upper eyelids, and prominent globes.[5351][5352][5353] A mimicking disorder has been encountered in soft contact lens (SCL) wearers, typically with exposure to thimerosal-preserved solutions.[5352] Treatment of SLK may involve the use of various medications, surgery, or a combination of both.[12328]","dateModified":"2017-01-03T00:00:00"},"basicQuestions":[{"questionId":6301,"questionText":"What are the symptoms of superior limbic keratoconjunctivitis (SLK)?","answerText":"The&nbsp;symptoms of SLK develop slowly over 1&nbsp;to 10 years and&nbsp;usually occur in both eyes (bilateral). Vision is&nbsp;rarely affected. The most common symptoms include burning, irritation and redness.[5352][5353] These symptoms may be more pronounced when&nbsp;looking&nbsp;up.[5352]&nbsp;","dateModified":"2016-10-06T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":5352,"authors":"Oakman JH","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 23, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1194578-overview","dateAccessed":"2016-10-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5353,"authors":"Papaliodis GN","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"The Ocular Immunology and Uveitis Foundation","date":"","volume":"","pages":"","url":"http://www.uveitis.org/docs/dm/superior_limbal_keratoconjunctivitis.pdf","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6300,"questionText":"What causes superior limbic keratoconjunctivitis (SLK)?","answerText":"The cause of&nbsp;SLK is&nbsp;unknown. One of the most common theories suggests that the development of SLK is related to laxity or a loosening of the superior bulbar conjunctiva (the clear layer that covers the eyeball, over the&nbsp;<a title=\"Sclera\" href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002295.htm\" target=\"_blank\"><span style=\"color: #0645ad;\">sclera</span></a>), resulting in friction and inflammation (swelling) between the&nbsp;upper eyelid and the eyeball. However, like other theories previously proposed, such as infectious, immunogenic and allergic, this theory lacks sufficient and convincing evidence to explain all of the developments of the disease.&nbsp;<sup class=\"reference\" id=\"cite_ref-7\"><a href=\"http://eyewiki.aao.org/Superior_limbic_keratoconjunctivitis#cite_note-7\"></a></sup>SLK may be associated with <a href=\"https://medlineplus.gov/thyroiddiseases.html\" target=\"_blank\">thyroid abnormalities</a>, particularly <a href=\"https://medlineplus.gov/hyperthyroidism.html\" target=\"_blank\">hyperthyroidism</a>, but is also found in individuals with normal thyroid function.[5352][5353]&nbsp;<sup class=\"reference\" id=\"cite_ref-7\"><a href=\"http://eyewiki.aao.org/Superior_limbic_keratoconjunctivitis#cite_note-7\"></a></sup><span>In advanced cases, superior limbal stem cell deficiency syndrome may occur from the repeated microtrauma to the limbal stem cells.[12870]</span><br />\r\n<br />\r\nA different condition, known as Contact Lens-Induced Superior Limbic Keratoconjunctivitis (CLSLK) is an eye inflammatory condition with an almost identical presentation, but it is related to contact lens wear.[12871]","dateModified":"2017-01-03T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":5352,"authors":"Oakman JH","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 23, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1194578-overview","dateAccessed":"2016-10-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5353,"authors":"Papaliodis GN","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"The Ocular Immunology and Uveitis Foundation","date":"","volume":"","pages":"","url":"http://www.uveitis.org/docs/dm/superior_limbal_keratoconjunctivitis.pdf","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12328,"authors":"Guillermo Mendoza, A., Rodríguez-García, A., Bernfeld, E, Feldman, B.","articleTitle":"Superior limbic keratoconjunctivitis","bookWebsiteJournalTitle":"American Academy of Ophthalmology","date":"August 15, 2015","volume":"","pages":"","url":"http://eyewiki.aao.org/Superior_limbic_keratoconjunctivitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12870,"authors":"Chelala E, El Rami H, Dirani A, Fakhoury H & Fadlallah A","articleTitle":"Extensive superior limbic keratoconjunctivitis in Graves’ disease: case report and mini-review of the literature","bookWebsiteJournalTitle":"Clinical Ophthalmology (Auckland, NZ)","date":"2015","volume":"9","pages":"467-468","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362972/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12871,"authors":"","articleTitle":"Contact Lens-Induced Superior Limbic Keratoconjunctivitis (CLSLK)","bookWebsiteJournalTitle":"Association of Optometric Contact Lens Educators","date":"May, 2016","volume":"","pages":"","url":"http://www.aocle.org/livingL/clslk.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6302,"questionText":"How might superior limbic keratoconjunctivitis (SLK) be treated?","answerText":"Many different methods have been used to try to manage SLK with varying levels of success. The most common treatment is large diameter contact lens wear.[5353][5354] Other options include:[5352][12328]<br />\r\n<ul>\r\n    <li><a href=\"https://www.britannica.com/science/silver-nitrate\" target=\"_blank\">Silver nitrate</a>&nbsp;(antiseptic) solution &nbsp;</li>\r\n    <li>Mast cell stabilizers (used to prevent or control allergic reactions)</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/002400.htm\" target=\"_blank\">Vitamin A</a> preparations&nbsp;</li>\r\n    <li><a href=\"https://medlineplus.gov/druginfo/meds/a601207.html\" target=\"_blank\">Cyclosporine A</a></li>\r\n    <li>Autologous (self) serum&ndash;derived drops</li>\r\n    <li><a href=\"https://medlineplus.gov/botox.html\" target=\"_blank\">Botulinum</a> injection to the overlying muscle </li>\r\n</ul>\r\nSurgical options include&nbsp;cryotherapy (use of cold to destroy abnormal tissue), conjunctival resection of the superior limbal conjunctiva, and thermal cautery of superior limbal conjunctiva, which may&nbsp;be curative.[5353][5354][12328]<br />\r\n<br />\r\n<span style=\"font-size: 12pt;\">More detailed information related to the treatment of SLK can be accessed through&nbsp;</span><a href=\"http://emedicine.medscape.com/article/1194578-treatment#showall\" target=\"_blank\" style=\"font-size: 12pt;\">Medscape Reference</a><span style=\"font-size: 12pt;\">.</span><br />","dateModified":"2017-01-03T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":5352,"authors":"Oakman JH","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 23, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1194578-overview","dateAccessed":"2016-10-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5353,"authors":"Papaliodis GN","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"The Ocular Immunology and Uveitis Foundation","date":"","volume":"","pages":"","url":"http://www.uveitis.org/docs/dm/superior_limbal_keratoconjunctivitis.pdf","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5354,"authors":"Fraunfelder FW","articleTitle":"Liquid nitrogen cryotherapy of superior limbic keratoconjunctivitis","bookWebsiteJournalTitle":"Am J Ophthalmol","date":"2009","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/18835475","dateAccessed":"2016-10-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12328,"authors":"Guillermo Mendoza, A., Rodríguez-García, A., Bernfeld, E, Feldman, B.","articleTitle":"Superior limbic keratoconjunctivitis","bookWebsiteJournalTitle":"American Academy of Ophthalmology","date":"August 15, 2015","volume":"","pages":"","url":"http://eyewiki.aao.org/Superior_limbic_keratoconjunctivitis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":6303,"questionText":"What is the long-term outlook for patients with superior limbic keratoconjunctivitis (SLK)?","answerText":"In general, the prognosis for&nbsp;SLK is excellent. While the symptoms may last for years, most cases go into remission or totally resolve over time.[5352]","dateModified":"2017-01-03T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5352,"authors":"Oakman JH","articleTitle":"Superior Limbic Keratoconjunctivitis","bookWebsiteJournalTitle":"Medscape Reference","date":"April 23, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1194578-overview","dateAccessed":"2016-10-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Superior_limbic_keratoconjunctivitis"}